-
公开(公告)号:AU2006244151B2
公开(公告)日:2012-05-17
申请号:AU2006244151
申请日:2006-05-05
Inventor: MANSON KELLEDY
IPC: C12N15/10
Abstract: Methods and compositions for detecting immune responses and antigen-specific cells are described herein.
-
公开(公告)号:AU2010202127B2
公开(公告)日:2012-04-05
申请号:AU2010202127
申请日:2010-05-26
Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH
Inventor: CHANG GWONG-JEN J
IPC: C12N15/09 , A61K39/00 , A61K39/12 , A61P31/14 , C07K14/18 , C07K16/10 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12Q1/70 , G01N33/53 , G01N33/569
Abstract: The present invention encompasses isolated nucleic acids containing transcriptional units which encode a signal sequence of one flavivirus and an immunogenic flavivirus antigen of a 5 second flavivirus or of a chimeric immunogenic flavivirus antigen comprising sequence from more than one flavivirus. The invention further encompasses a nucleic acid and protein vaccine and the use of the vaccine to immunize a subject against flavivirus infection. The invention also provides antigens encoded by nucleic acids of the invention, antibodies elicited in response to the antigens and use of the antigens and/or antibodies in detecting flavivirus or 10 diagnosing flavivirus infection.
-
公开(公告)号:AU2005289439B2
公开(公告)日:2011-12-01
申请号:AU2005289439
申请日:2005-09-27
Applicant: CRUCELL HOLLAND BV , THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY
Inventor: GRAZIA PAU MARIA , NABEL GARY J , BIMAL CHAKRABARTI , NANCY SULLIVAN , ZHI-YONG YANG , JAAP GOUDSMIT
IPC: C07K14/08 , A61K39/12 , C07K16/10 , C12N15/861
Abstract: The invention is related to a nucleic acid molecule comprising a polynucleotide encoding a modified filovirus glycoprotein (GP) having at least one amino acid change located in a relatively conserved region of said GP that decreases cytotoxicity and retains immunogenicity when compared to cytotoxicity and immunogenicity of a wild type filovirus GP, and related modified filovirus GPs, plasmid DNAs, recombinant viruses, adenoviruses, pharmaceutical compositions, vaccine compositions, antibodies that are specifically reactive with the modified filovirus GPs, and related methods of making and using the same.
-
公开(公告)号:AU2009200792B2
公开(公告)日:2011-11-10
申请号:AU2009200792
申请日:2009-02-27
Inventor: DIMITROV DIMITER S , MEI-YUN ZHANG
Abstract: The present invention provides a method of identifying novel broadly crossreactive neutralizing monoclonal anti-bodies using sequential antigen panning of phage display libraries, antibodies obtained in accordance with such a method, as well as fusion proteins and conjugates comprising same, and related isolated or purified nucleic acid molecules, vectors, host cells, compositions, and methods of use to inhibit an infection, reduce the severity of an infection, treat an infection, treat an infection, and inhibit cancer. Flow chart of sequential antigen panning (m12 and m14) pComb3H phage Preabsorption on pre-washed M-280 streptavidin beads Depletion with sCD4 1" round of panning (rp) against 50 nM biotinylated gpl40sg. 6-sCD4 1" round panned library Preabsorption on pre-washed M-280 streptavidin beads Depletion with sCD4 2 nd rp against 10 nM biotinylated gpl4089.6-sCD4 complexes 2 "d round panned library Preabsorption on pre-washed M-280 streptavidin beads 3 rd rp against 2 nM biotinylated gpl40sg.6-sCD4 complexes 3rd round panned library 4, rp against 2 nM biotinylated gpl40WHXB2-SCD4 complexes 4h round panned library screen individual clones from 4*, 5* and 6"1 round panned libraries by phage ELISA using gpl20/l4089.6/HBx2 and gpl20 Ma and their complexes with sCD4 as antigens selection of clones with highest binding activity to all antigens
-
75.
公开(公告)号:AU2006213996B2
公开(公告)日:2011-08-11
申请号:AU2006213996
申请日:2006-02-21
Inventor: THOMAS RIED , SONIA ANDERSSON , CATHARINA LARSSON , WINFRIED STEINBERG , GERT AUER , KERSTIN HESELMEYER-HADDAD
IPC: C12Q1/68
Abstract: The invention provides methods for identifying conditions of low grade cervical dysplasia and assessing the progressive potential of individual lesions to develop into high grade cervical dysplasia and cervical squamous cell cancer as well as cervical adenocarcinoma.
-
公开(公告)号:AU2006203490B9
公开(公告)日:2011-01-20
申请号:AU2006203490
申请日:2006-08-11
Inventor: SIEGEL RICHARD M , LENARDO MICHAEL J , CHAN FRANCIS KA-MING
IPC: C07K14/715 , C12N15/12
Abstract: The present invention provides a polypeptide comprising the isolated amino acid sequence of a pre-ligand assembly domain (PLAD) of a TNF-like receptor. Also provided by this invention is a polypeptide comprising the isolated amino acid sequence of a pre-ligand assembly domain (PLAD), wherein the PLAD is selected from the group consisting of: the PLAD of a TNF-R, the PLAD of p60, the PLAD of p80, the PLAD of Fas (CD95/APO-1), the PLAD of TRAIL receptors, the PLAD of LT&bgr;R, the PLAD of CD40, the PLAD of CD30, the PLAD of CD27, the PLAD of HVEM, the PLAD of OX40 and the PLAD of DR4. TNF-R, p60, p80, Fas, TRAIL receptor, LT&bgr;R, CD40, CD30, CD27, HVEM, OX40, DR4, TROY, EDAR, XEDAR, DCR3, AITR, 4-1BB, DR3, RANK, TACI, BCMA, DR6, DPG, DR5, DCR1 AND DCR2 are all members of the TNF receptor superfamily or the TNF-like receptor family. The invention also provides the PLAD for other members of the TNF receptor superfamily. The polypeptides of the present invention can be utilized to inhibit oligomerization of members of the TNF receptor superfamily. These polypeptides can also be utilized to inhibit ligand binding to members of the TNF receptor superfamily. The present invention also provides a composition comprising an inhibitor of TNF receptor oligomerization. Further provided by this invention are members of the TNF receptor superfamily that are lacking a PLAD.
-
公开(公告)号:AU2004262022B2
公开(公告)日:2010-10-28
申请号:AU2004262022
申请日:2004-08-02
Inventor: GEISBERT THOMAS W , SULLIVAN NANCY J , JAHRLING PETER B , NABEL GARY J
Abstract: The present invention relates to genetic vaccines for stimulating cellular and humoral immune responses in humans and other hosts, and, in particular, relates to recombinant viruses that express heterologous antigens of pathogenic viruses, in single dose form.
-
公开(公告)号:AU2003297155B2
公开(公告)日:2010-03-18
申请号:AU2003297155
申请日:2003-12-15
Inventor: WALDMANN THOMAS A , BERZOFSKY JAY A , PERERA LIYANGE P , OH SANG-KON
Abstract: The invention is directed to compositions capable of augmenting the immunogenicity of a vaccine. The composition, or adjuvant, is administered to a mammal in need thereof in sequential or concurrent combination with a vaccine antigen. In one preferred aspect, the adjuvant is provided in the form of a recombinant poxvirus vector, such as a vaccinia virus vector, which comprises a nucleic acid sequence encoding IL-15.
-
公开(公告)号:AU2006202170B2
公开(公告)日:2009-10-08
申请号:AU2006202170
申请日:2006-05-23
Applicant: THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY US DEPARTMENT OF HEALTH
Inventor: WHITEHEAD STEPHEN S , KREMPL CHRISTINE D , MURPHY BRIAN R , BUCHHOLZ URSULA , COLLINS PETER L
IPC: C12N15/09 , C12N15/86 , A61K39/00 , A61K39/12 , A61P11/00 , C07K14/14 , C12N7/00 , C12N7/04 , C12R1/93
Abstract: Chimeric human-bovine respiratory syncytial virus (RSV) are infectious and attenuated in humans and other mammals and useful in vaccine formulations for eliciting an anti-RSV immune response. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric RSV genome or antigenome which includes a partial or complete human or bovine RSV “background” genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) of a different RSV strain. In preferred aspects of the invention, chimeric RSV incorporate a partial or complete bovine RSV background genome or antigenome combined with one or more heterologous gene(s) or genome segment(s) from a human RSV. A variety of additional mutations and nucleotide modifications are provided within the human-bovine chimeric RSV of the invention to yield desired phenotypic and structural effects.
-
80.
公开(公告)号:AU2003239356B2
公开(公告)日:2009-06-25
申请号:AU2003239356
申请日:2003-05-06
Inventor: DIMITROV DIMITER S , ZHANG MEI-YUN
Abstract: The present invention provides an antibody to human immunodeficiency virus (HIV) envelope glycoprotein that can recognize one or more strains of HIV, wherein the epitope of HIV recognized by the antibody is inducible, and wherein the antibody binding to the epitope is enhanced by the presence of CD4 and the HIV co-receptor, and related fusion proteins, conjugates, nucleic acids, vectors, host cells, compositions and methods of use to inhibit an infection of a human at risk of becoming infected with HIV, to reduce the severity of an infection of a human infected with HIV, and to treat an infection of a human with HIV.
-
-
-
-
-
-
-
-
-